WhitneyNicoleGoldsberryMD

PubMed

• Bilateral adnexal masses: A case report of acute myeloid leukemia presenting with myeloid sarcoma of the ovary and review of literature.
  Jenci Hawthorne, Hajrunisa Cubro, Elizabeth Farabee, Samer Z Al-Quran, Mustafa Al-Kawaaz, Semir Vranic, Whitney Goldsberry, Daniel Metzinger, Sarah Todd> ;Gynecologic Oncology Reports. 2023 Jun 1
• Society of Gynecologic Oncology Journal Club: Controversial conversations in gynecologic cancer - Navigating maintenance therapy for homologous recombinant proficient ...
  Whitney N Goldsberry, Barbara S Norquist, Rodney P Rocconi, Susan C Modesitt, Renata R Urban> ;Gynecologic Oncology Reports. 2022 Dec 1
• 9 citations
  Sequential modulation of the Wnt/β-catenin signaling pathway enhances tumor-intrinsic MHC I expression and tumor clearance.
  Jhalak Dholakia, Carly Bess Scalise, Ashwini A. Katre, Whitney N. Goldsberry, Selene Meza-Perez, Troy D. Randall, Lyse A. Norian, Lea Novak, Rebecca C. Arend> ;Gynecologic Oncology. 2021 Nov 26
• 1 citations
  Overcoming the barriers to HPV vaccination in high-risk populations in the U.S.: A Society of Gynecologic Oncology (SGO) Review.
  Deanna Gek Koon Teoh, Emily K. Hill, Whitney N. Goldsberry, L. Levine, Akiva P. Novetsky, L. Downs> ;Gynecologic Oncology. 2021 Mar 9
• 3 citations
  Neutralization of TGFβ Improves Tumor Immunity and Reduces Tumor Progression in Ovarian Carcinoma.
  Brandon M. Roane, Selene Meza-Perez, Ashwini A. Katre, Whitney N. Goldsberry, Troy D. Randall, Lyse A. Norian, Michael J. Birrer, Rebecca C. Arend> ;Molecular Cancer Therapeutics. 2021 Mar 1
• 9 citations
  The financial burden of PARP inhibitors on patients, payors, and financial assistance programs: Who bears the cost?
  Whitney N. Goldsberry, Sarah S. Summerlin, Allison Guyton, Brittani Caddell, Warner K. Huh, Kenneth H. Kim, Margaret I. Liang> ;Gynecologic Oncology. 2021 Mar 1
• 21 citations
  Inhibition of the Wnt/β-catenin pathway enhances antitumor immunity in ovarian cancer.
  David W. Doo, Selene Meza-Perez, Angelina I. Londono, Whitney N. Goldsberry, Ashwini A. Katre, Jonathan D. Boone, Dylana Moore, Cindy T. Hudson, Ilaria Betella, Tyler ...> ;Therapeutic Advances in Medical Oncology. 2020 Apr 14
• 15 citations
  Inhibiting WNT Ligand Production for Improved Immune Recognition in the Ovarian Tumor Microenvironment.
  Whitney N. Goldsberry, Selene Meza-Perez, Angelina I. Londono, Ashwini A. Katre, Bryan T. Mott, Brandon M. Roane, Nidhi Goel, Jaclyn A. Wall, Sara J. Cooper, Lyse A. N...> ;Cancers. 2020 Mar 24
• 44 citations
  A Review of the Role of Wnt in Cancer Immunomodulation
  Whitney N. Goldsberry, Angelina I. Londono, Troy D. Randall, Lyse A. Norian, Rebecca C. Arend> ;Cancers. 2019 Jun 4
• The Role of Barrels 1 and 2 in the Enzymatic Activity of Factor XIII‐A
  Whitney Goldsberry, MD> ;Journal of Thrombosis and Haemostasis.
• 2 citations
  Screening cleavage of Factor XIII V34X Activation Peptides by thrombin mutants: A strategy for controlling fibrin architecture.
  Madhavi A. Jadhav, Whitney N. Goldsberry, Sara E. Zink, Kelsey N. Lamb, Katelyn E. Simmons, Carmela M. Riposo, Boris A. Anokhin, Muriel C. Maurer> ;Biochimica Et Biophysica Acta. Proteins and Proteomics. 2017 Oct 1
• 2 citations
  Robotic Cystotomy for Pessary Extraction With Vesicovaginal Fistula Repair
  Whitney N. Goldsberry, Daniel S. Metzinger> ;Journal of Minimally Invasive Gynecology. 2017 Feb 4
• 5 citations
  Factors Associated with Infant Feeding Choices in the Adolescent Population.
  Jennifer M. Godbout, Whitney N. Goldsberry, Tanya E. Franklin> ;Journal of Human Lactation. 2016 Aug 22
• 2 citations
  Design of Factor XIII V34X activation peptides to control ability to interact with thrombin mutants.
  Madhavi A. Jadhav, R. Cory Lucas, Whitney N. Goldsberry, Muriel C. Maurer> ;Biochimica Et Biophysica Acta. 2011 Jul 21
• Join now to see all

Lectures

• The effects of Wnt inhibition on tumor progression and the tumor microenvironment in a syngeneic mouse model of ovarian cancer. 
  2019 ASCO Annual Meeting - 6/1/2019